{"description":"At each visit the investigator had to document any occurrence of adverse events and abnormal laboratory findings. Any event spontaneously reported by the participant or observed by the investigator was recorded, irrespective of the relation to study treatment.","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":43,"description":"Ixazomib 4 mg, capsules, orally, once on Days 1, 8, and 15; lenalidomide 25 mg, capsules, orally, once on Days 1 through 21; and dexamethasone 40 mg, tablets, orally, once on Days 1, 8, 15, and 22 of a 28-day treatment cycle until progressive disease (PD) or unacceptable toxicity (up to 20 cycles)","id":"EG000","otherNumAffected":43,"otherNumAtRisk":43,"seriousNumAffected":18,"seriousNumAtRisk":43,"title":"Ixazomib+Lenalidomide+Dexamethasone"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":43}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":43}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":43}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":43}],"term":"Cataract"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":23,"numAtRisk":43}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":43}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":43}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":43}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Abdominal discomfort"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Dyspepsia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Abdominal pain upper"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":43}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":43}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43}],"term":"Influenza like illness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":43}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Influenza"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Spinal compression fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":43}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":43}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Weight decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Blood alkaline phosphatase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Gamma-glutamyltransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":43}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":43}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43}],"term":"Hypocalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Hypomagnesaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Hypophosphataemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Hypercalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Muscle spasms"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Muscular weakness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Musculoskeletal chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Musculoskeletal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":43}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":43}],"term":"Neuropathy peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43}],"term":"Hypoaesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Lethargy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Peripheral sensory neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":43}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":43}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43}],"term":"Productive cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Rhinorrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43}],"term":"Rash pruritic"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43}],"term":"Dry skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43}],"term":"Rash macular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Skin hyperpigmentation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Pruritus generalised"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43}],"term":"Hypertension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43}],"term":"Lung infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Diarrhoea infectious"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Gastroenteritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Gastritis atrophic"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Osteoporotic fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43}],"term":"Plasmacytoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Renal cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"General physical health deterioration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Drug hypersensitivity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Food allergy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Laceration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Spinal fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Hypophagia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Presyncope"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Spinal cord compression"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA version: 16.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43}],"term":"Renal impairment"}],"timeFrame":"First dose of study drug through 30 days after the last dose of study drug (up to 577 days)"}